Market Research Logo

Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review

Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Johnson & Johnson (J&J) engages in the research and development, manufacture and sale of a range of healthcare products. Its primary focus is on the development of products related to human health and well-being. The company provides pharmaceuticals in immunology, cancer, neuroscience, infectious, cardiovascular and metabolic diseases areas; consumer products in baby care, oral care, beauty, over-the-counter (OTC) pharmaceutical, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopedic, surgery, diabetes care and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and consumer products through retail outlets and distributors. The company provides its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.

Johnson & Johnson Key Recent Developments

Mar 20,2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson
Feb 26,2018: New Late-Breaking XARELTO (rivaroxaban) and INVOKANA (canagliflozin) Data to be Presented at the American College of Cardiology's Annual Scientific Session
Jan 23,2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results
Dec 13,2017: Janssen and Leading Advocacy Organizations Introduce Cancer.com, a Customizable Online Destination for People Impacted by Cancer
Dec 05,2017: Bioethics International Releases the Good Pharma Scorecard in BMJ Open, Ranking the Top 20 Largest Pharmaceutical Companies on Clinical Trial Transparency

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Johnson & Johnson - Key Facts
Johnson & Johnson - Key Employees
Johnson & Johnson - Key Employee Biographies
Johnson & Johnson - Major Products and Services
Johnson & Johnson - History
Johnson & Johnson - Company Statement
Johnson & Johnson - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Johnson & Johnson - Business Description
Business Segment: Consumer
Overview
Performance
Key Stats
Business Segment: Medical Devices
Overview
Performance
Key Stats
Business Segment: Pharmaceutical
Overview
Business Segment: Pharmaceuticals
Performance
Key Stats
Geographical Segment: Asia-Pacific, Africa
Performance
Geographical Segment: Europe
Performance
Geographical Segment: United States
Performance
Geographical Segment: Western Hemisphere excluding U.S.
Performance
R&D Overview
Johnson & Johnson - Corporate Strategy
Johnson & Johnson - SWOT Analysis
SWOT Analysis - Overview
Johnson & Johnson - Strengths
Johnson & Johnson - Weaknesses
Johnson & Johnson - Opportunities
Johnson & Johnson - Threats
Johnson & Johnson - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Johnson & Johnson, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson
Feb 26, 2018: New Late-Breaking XARELTO (rivaroxaban) and INVOKANA (canagliflozin) Data to be Presented at the American College of Cardiology's Annual Scientific Session
Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results
Dec 13, 2017: Janssen and Leading Advocacy Organizations Introduce Cancer.com, a Customizable Online Destination for People Impacted by Cancer
Dec 05, 2017: Bioethics International Releases the Good Pharma Scorecard in BMJ Open, Ranking the Top 20 Largest Pharmaceutical Companies on Clinical Trial Transparency
Nov 30, 2017: New HIV Prevention Trials Hold Promise for New Prevention Options for Women
Nov 16, 2017: Federal Jury Returns $247 Million Verdict in Defective Hip Implants Case
Nov 03, 2017: Johnson & Johnson wins Contract for Medical Surgical Products
Nov 01, 2017: Decision Diagnostics CEO Offers Primary Update on Legal Proceedings, Potential Outcomes, History, and Synopsis on Its Strategic Suit Against J&J
Oct 31, 2017: Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At ObesityWeek 2017
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Johnson & Johnson, Key Facts
Johnson & Johnson, Key Employees
Johnson & Johnson, Key Employee Biographies
Johnson & Johnson, Major Products and Services
Johnson & Johnson, History
Johnson & Johnson, Subsidiaries
Johnson & Johnson, Key Competitors
Johnson & Johnson, Ratios based on current share price
Johnson & Johnson, Annual Ratios
Johnson & Johnson, Annual Ratios (Cont...1)
Johnson & Johnson, Annual Ratios (Cont...2)
Johnson & Johnson, Interim Ratios
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Johnson & Johnson, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Johnson & Johnson, Performance Chart (2013 - 2017)
Johnson & Johnson, Ratio Charts
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report